ACA
TMO icon

Aptus Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Aptus Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600,000
Closed -$291M – 1733
2025
Q3 		$291M Sell
600,000
-200,000
-25% -$93.1M 2.12% 6
2025
Q2 		$324M Buy
+800,000
New +$334M 2.64% 5

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aptus Capital Advisors's TMO Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 20% in Q1 2026, selling an estimated $6.35M and leaving 46,240 shares worth $22.7M. The position accounts for 0.18% of the portfolio, ranked #107.

Aptus Capital Advisors first reported a position in TMO in Q1 2020 and has held it in 25 quarters since. The position peaked at $33.6M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aptus Capital Advisors held 46,240 shares of Thermo Fisher Scientific worth $22.7M as of Q1 2026.
  • Aptus Capital Advisors sold 11,704 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.35M.
  • Thermo Fisher Scientific made up 0.18% of Aptus Capital Advisors's portfolio in Q1 2026, its #107 holding.
  • Aptus Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 25 quarters since.
  • Aptus Capital Advisors's Thermo Fisher Scientific position peaked at $33.6M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.